CombiMatrix Reaches $5.5M Milestone As it Readies Custom Arrays for Market | GenomeWeb

Semiconductor microarray company CombiMatrix is approaching two milestones in the next two weeks in the commercialization of its technology.

The company is rolling out its CombiMatrix custom chip technology, developed and marketed in collaboration with Roche Applied Science, and said earlier this week it would receive $5.5 million during the fourth quarter from Roche as a milestone payment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.